Tolmar Therap patents expiration

1. Eligard Kit patents expiration

ELIGARD KIT's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8470359 TOLMAR THERAP Sustained release polymer
Oct, 2023

(23 days from now)

Drugs and Companies using LEUPROLIDE ACETATE ingredient

Market Authorisation Date: 24 July, 2002

Treatment: Method of treating cancer


More Information on Dosage

ELIGARD KIT family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic